Regulatory reports

Regulatory report: Netherlands, February 2021

Written by Dmytro Korchahin || 15th February 2021 || Regulatory reports |

The broad legal framework for hemp, CBD and medical cannabis in the Netherlands will remain unchanged for now due to upcoming parliamentary elections. This report covers the current rules for cannabis and CBD ...

Regulatory report: Canada, February 2021

Written by Anthony Traurig || 8th February 2021 || Regulatory reports |

Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules ...

Regulatory report: Philippines, January 2021

Written by Elsa Carrasco || 13th January 2021 || Regulatory reports |

A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the...

Regulatory report: North Macedonia, January 2021

Written by CBD-Intel || 11th January 2021 || Regulatory reports |

Unlike psychoactive cannabis, cultivation and processing of industrial hemp is not allowed in North Macedonia – however this may change. This report offers an overview of the current and likely future legal framework ...

Regulatory report: Italy, November 2020

Written by Lorenzo Guaragna || 16th November 2020 || Regulatory reports |

The Italian regulatory landscape differentiates between hemp and cannabis. This report offers a detailed overview of the current regime for CBD as well as for medical and recreational cannabis ...

Regulatory report: Greece, November 2020

Written by Elsa Carrasco || 5th November 2020 || Regulatory reports |

There is currently no specific national legislation in Greece relating to CBD, nor are there any restrictions that could prohibit the sale and import of CBD isolates, provided that the CBD source complies with relevant laws ...

Regulatory report: Australia, October 2020

Written by CBD-Intel || 15th October 2020 || Regulatory reports |

CBD is listed on the Controlled Drug Register in Australia, which means it cannot be sold as a consumer product. This report offers an overview of the current regulatory framework in the country for CBD ...

Regulatory report: Brazil, October 2020

Written by Marija Obradovic || 6th October 2020 || Regulatory reports |

A recent proposal in Brazil could see the legalisation of hemp cultivation for industrial purposes and cannabis for medical use. This report provides an overview of the current regulatory framework ...

Regulatory report: Lithuania, August 2020

Written by CBD-Intel || 4th August 2020 || Regulatory reports |

This regulatory report provides a detailed analysis of the current regulations in place in Lithuania, as well as discussing possible future legislation that could change the legal framework ...

Regulatory report: Uruguay, July 2020

Written by Lenka Hajnovicova || 15th July 2020 || Regulatory reports |

This report offers a comprehensive overview of the regulatory regime for CBD and cannabis in Uruguay, including rules around extracts, finished products, import/export and medicinal and recreation cannabis ...

Regulatory report: Ukraine, July 2020

Written by CBD-Intel || 9th July 2020 || Regulatory reports |

The Ukrainian legal framework distinguishes between industrial hemp and cannabis. This report provides a clear analysis of the current regulatory framework for CBD and related products in Ukraine ...

Regulatory report: Romania, June 2020

Written by Elsa Carrasco || 30th June 2020 || Regulatory reports |

Pure CBD is not a scheduled substance in Romania. This report examines the current regulatory framework for hemp and CBD in Romania, covering all aspects from import and export to medical and recreational cannabis ...

Regulatory report: Jilin province, China

Written by CBD-Intel || 1st June 2020 || Regulatory reports |

Jilin province is the third province in China to be actively working on hemp regulation. This report offers an analysis on the potential upcoming regulations, looking at all aspects from imports to cultivation ...

Regulatory report: Hong Kong, May 2020

Written by CBD-Intel || 19th May 2020 || Regulatory reports |

This report provides an overview of the current regulatory landscape for CBD and hemp in Hong Kong, including analysis of the restrictions relating to medical and recreational cannabis ...

Regulatory report: South Korea, May 2020

Written by Marija Obradovic || 18th May 2020 || Regulatory reports |

This report offers our analysis of the regulatory regime in South Korea for CBD and related products, including extracts and finished products, their import and export, and medical and recreational cannabis ...

Regulatory report: Czech Republic, May 2020

Written by Lenka Hajnovicova || 14th May 2020 || Regulatory reports |

This report offers a thorough overview of the current regulatory regime for CBD in the Czech Republic, covering all aspects from extracts and finished products to medical and recreational cannabis ...

Regulatory report: Oklahoma, April 2020

Written by Berta Camps Bisbal || 28th April 2020 || Regulatory reports |

This report offers an overview of the regulatory landscape in the US state of Oklahoma, including information on cultivation, finished products and import/export restrictions ...

Regulatory report: Colombia, April 2020

Written by CBD-Intel || 24th April 2020 || Regulatory reports |

Cultivation of cannabis and manufacture of cannabis-derived products is permitted in Colombia under a licence. This report provides all current regulatory information in place in the country ...

Regulatory report: Mexico, April 2020

Written by Lenka Hajnovicova || 23rd April 2020 || Regulatory reports |

Cultivation and processing of hemp is currently not allowed in Mexico, however there have been recent proposals for legalisation. This report provides an overview of the current regulatory landscape, as well as likely future regulation ...

Regulatory report: Croatia, April 2020

Written by CBD-Intel || 16th April 2020 || Regulatory reports |

Pure CBD is not itself regulated under the Croatian drug regime. This report provides a detailed overview of the current regulatory framework, including finished products, extracts, medical and recreational cannabis ...

Regulatory report: Texas snapshot, February 2020

Written by Berta Camps Bisbal || 25th February 2020 || Regulatory reports |

The regulatory snapshot gives a comprehensive overview of the current regulatory landscape in Texas, detailing import and export laws, rules around vaping, cosmetic and pet food products as well as foodstuffs ...